BioXcel Therapeutics (BTAI) Return on Sales Growth (3y) (2025 - 2026)

BioXcel Therapeutics (BTAI) Return on Sales Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Haleon 88.88 Bn 87.01 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 0.00
3 Zoetis 32.31 Bn 30.37 Bn 1.62 Bn 0.00
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -1.00
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn 0.00
6 RedHill Biopharma 20.53 Bn 20.53 Bn - -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn 0.00
8 Neurocrine Biosciences 17.92 Bn 16.61 Bn 800.70 Mn 0.00
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn 0.00
10 BioXcel Therapeutics 20.43 Mn 20.43 Mn -77,000.00 345.00

Historic Data

Download Data
DateValue
Mar 31, 2026 345.00
Dec 31, 2025 657.00
Sep 30, 2025 244.00